Intranasal Chlorpheniramine for Early Symptomatic Treatment of COVID-19 and the Impact on Long-COVID

Gustavo Ferrer • Fernando Valerio-Pascua • César Alas-Pineda • et.al., DOI: 10.7759/cureus.82736  Abstract This review explores the therapeutic potential of intranasal chlorpheniramine maleate (iCPM) in managing both acute COVID-19 and Long COVID by integrating histamine H1 receptor…[...]

Read More

IgA autoimmunity and coagulation: post-acute sequelae of SARS-CoV-2 infection (PASC)

Claudia Gomes1,Jonathan H. Whiteson2,3,Fabio Ponzo4,et. al. Introduction: The SARS-CoV-2 virus resulted in significant disability and diagnostic challenges among patients with Post-Acute Sequelae of COVID-19 (PASC). Here, we assessed microvascular perfusion, clotting,…[...]

Read More

No American Has Ever Said, “I Regret Refusing the Covid Vaccine.” So, Here are Three Simple, Easy, Reasonable, Moderate Steps President Trump Can Take to Keep Us Safe.

by Assistant Editor GWP, Wayne Allyn Root Look around. No one wants the latest Covid-19 booster. Do you know why? It’s the dirtiest secret in America. The mainstream media won’t tell you…[...]

Read More

Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics

Grant McGee Talkington, Paresh Kolluru, Timothy E. Gressett, et. al. One lingering effect of the COVID-19 pandemic created by SARS-CoV-2 is the emergence of Long COVID (LC), characterized by enduring…[...]

Read More

Progressive Systemic Sclerosis-Associated Interstitial Lung Disease With Clinical-Radiographic Dissociation

Nicolas Bakinde • Antoinette Johnson • Deborah Ngo Bakinde • Priscilla Pemu • Eric Flenaugh, DOI: 10.7759/cureus.86412  Abstract Systemic sclerosis-associated interstitial lung disease (ILD) is a major contributor to morbidity and mortality in patients with diffuse systemic sclerosis. We…[...]

Read More